|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Current operating lease liability | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Dividend payable | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Convertible Preferred stock, par value $0.01, 15,000,000 shares authorized Series L - 6,301 and 0 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | ||||||||||||||||||||
| Series L Preferred Stock | ||||||||||||||||||||
| Total convertible Preferred stock, par value $0.01, 15,000,000 shares authorized Series L - 6,301 and 0 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Preferred stock value | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Total preferred stock value | ||||||||||||||||||||
| Common stock, par value $0.001, 250,000,000 shares authorized, 44,668,969 and 25,534,173 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
Loading...